DUARTRON 625 mg HARD CAPSULES
How to use DUARTRON 625 mg HARD CAPSULES
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
Duartron 625 mg Hard Capsules
Glucosamine
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this package leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. See section 4.
The name of this medicine is Duartron 625 mg Hard Capsules. However, the product will be referred to as Duartron in the package leaflet text.
Contents of the Package Leaflet
- What is Duartron and what is it used for
- What you need to know before you take Duartron
- How to take Duartron
- Possible side effects
- Storage of Duartron
- Contents of the pack and further information
1. What is Duartron and what is it used for
Duartron belongs to a group of medicines called other anti-inflammatory and anti-rheumatic non-steroidal compounds.
Duartron contains the active ingredient glucosamine.
Duartron is indicated for the relief of symptoms produced by mild to moderate knee osteoarthritis.
2. What you need to know before you take Duartron
Do not take Duartron:
- if you are allergic to glucosamine or any of the other ingredients of this medicine (listed in section 6).
- if you are allergic to shellfish, as glucosamine is obtained from shellfish.
Warnings and precautions
Consult your doctor or pharmacist before taking Duartron.
- if you have glucose intolerance. More frequent monitoring of blood glucose levels may be necessary when starting treatment with Duartron.
- if you have any risk factors for heart disease, as an increase in cholesterol has been observed in some patients treated with glucosamine.
- if you have asthma. When starting treatment with glucosamine, you should be aware that symptoms may worsen.
- if you have kidney or liver problems, as no studies have been conducted in this group of patients, and dosage recommendations cannot be given.
Other medicines and Duartron
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Caution is recommended if Duartron is administered in combination with other medicines, especially:
- Certain types of medicines used to prevent blood clotting (e.g., warfarin, dicumarol, phenprocoumon, acenocoumarol, and fluindione). The effect of these medicines may be enhanced if used with glucosamine. Therefore, patients treated with these combinations should be closely monitored at the start or end of treatment with glucosamine.
- Tetracyclines (antibiotics for treating infections).
Taking Duartron with food and drink
Duartron can be taken with food and drink, before, during, or after meals.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Duartron should not be used during pregnancy.
The use of Duartron is not recommended during breastfeeding.
Driving and using machines
No studies have been conducted on how Duartron affects the ability to drive and use machines.
However, if you experience dizziness or drowsiness due to the capsules, you should not drive or operate machinery.
3. How to take Duartron
Follow exactly the administration instructions of the medicine given by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.
The recommended dose is 2 capsules per day in a single intake (1,250 mg of glucosamine).
Swallow the capsules with a sufficient amount of water. Do not chew the capsules.
Glucosamine is not indicated for the treatment of acute pain. Relief of symptoms (especially pain relief) may not be apparent until after several weeks of treatment, and sometimes even longer. If no improvement is observed after 2-3 months, please consult your doctor.
Use in children and adolescents
Duartron is not recommended for use in children or adolescents under 18 years of age.
If you take more Duartron than you should
If you have taken more Duartron capsules than you should, you may experience headache, dizziness, disorientation, joint pain, nausea, vomiting, or diarrhea, although you may not experience any symptoms. In any case, inform your doctor.
If you forget to take Duartron
If you forget to take a dose, simply take the next dose as scheduled. Do not take a double dose to make up for the forgotten doses.
If you stop taking Duartron
Continue taking this medicine until your doctor tells you to stop. Do not stop taking it just because you feel better. If you stop taking this medicine, your disease may recur.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. These are usually mild and temporary.
Serious side effects
Stop taking glucosamine and seek immediate medical attention if you experience any of the following symptoms, as they may indicate a severe allergic reaction to this medicine:
- Swelling of the face, tongue, throat
- Difficulty swallowing or breathing
- Skin rash or hives
Other side effects
Common(may affect up to 1 in 10 people):
Headache, fatigue, nausea, abdominal pain, indigestion, diarrhea, constipation.
Uncommon(may affect up to 1 in 100 people):
Rash, itching, redness.
Frequency not known(cannot be estimated from the available data):
Vomiting, hives, dizziness, swelling in feet or ankles, angioedema. Worsening of existing asthma, in diabetic patients worsening of blood glucose control.
High cholesterol levels have also been reported. It has not been possible to determine whether these effects are directly related to glucosamine.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Duartron
Keep this medicine out of the sight and reach of children.
Store below 30°C. Store in the original packaging to protect from moisture.
Do not use this medicine after the expiry date stated on the carton after EXP. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for proper disposal. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and further information
Composition of Duartron
- The active ingredient is glucosamine. Each capsule contains 625 mg of glucosamine (equivalent to 750 mg of glucosamine hydrochloride).
- The other ingredient is magnesium stearate.
Composition of the capsule:gelatin, iron oxide (E172), titanium dioxide (E171), black iron oxide (E172).
Appearance and packaging of the product
Duartron is presented as hard gelatin capsules of brown color.
Duartron is packaged in a cardboard box containing 60 and 180 capsules in blisters.
Only certain pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
LABORATORIO REIG JOFRE, S.A.
C/Gran Capitán 10
08970 Sant Joan Despí (Barcelona)
Spain
Manufacturer:
NOUCOR HEALTH, S.A.
Av. Camí Reial 51-57
08184 Palau-solità i Plegamans (Barcelona)
Spain
Date of last revision of this package leaflet
April 2018
Other sources of information
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products: http://www.aemps.gob.es.
- Country of registration
- Average pharmacy price6.51 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to DUARTRON 625 mg HARD CAPSULESDosage form: EFFERVESCENT TABLET, 1250 mgActive substance: glucosamineManufacturer: Especialidades Farmaceuticas Centrum S.A.Prescription requiredDosage form: ORAL SOLUTION/SUSPENSION, 1500 mg of glucosamine sulfateActive substance: glucosamineManufacturer: Laboratorio Reig Jofre, S.A.Prescription requiredDosage form: ORAL SOLUTION/SUSPENSION, 1500 mgActive substance: glucosamineManufacturer: Laboratorios Cinfa S.A.Prescription required
Online doctors for DUARTRON 625 mg HARD CAPSULES
Discuss questions about DUARTRON 625 mg HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
